Literature DB >> 18180495

Changes in Medicaid prescription volume and use in the wake of Medicare Part D implementation.

Brian K Bruen1, Laura M Miller.   

Abstract

Implementation of the Medicare drug benefit resulted in a major shift of prescription drug spending from Medicaid to Medicare. Data indicate that Medicaid programs experienced substantial changes in the volume and types of prescriptions used by enrollees. Medicaid prescription volume and total payments to pharmacies dropped by almost 50 percent in 2006. Generic dispensing rates increased 4.6 percentage points nationally. The mix of drug classifications also shifted, reflecting the younger makeup of the population that remains eligible for Medicaid prescription drug benefits. Still, patterns of use reflect the major mental and physical health needs of Medicaid enrollees.

Mesh:

Year:  2008        PMID: 18180495     DOI: 10.1377/hlthaff.27.1.196

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008.

Authors:  Meng-Yun Wu; Jae Kennedy; Lawrence J Cohen; Chi-Chuan Wang
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 2.  Influencers of generic drug utilization: A systematic review.

Authors:  Jennifer N Howard; Ilene Harris; Gavriella Frank; Zippora Kiptanui; Jingjing Qian; Richard Hansen
Journal:  Res Social Adm Pharm       Date:  2017-08-04

3.  Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019.

Authors:  Mohammed M Alsultan; Jeff Jianfei Guo
Journal:  Am Health Drug Benefits       Date:  2022-03

4.  Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991-2015.

Authors:  Ziyad S Almalki; Xiaomeng Yue; Ying Xia; Patricia R Wigle; Jeff Jianfei Guo
Journal:  Pharmacoecon Open       Date:  2017-06

5.  Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.

Authors:  Shuo-Yu Lin; Kyle Baumann; Chenxuan Zhou; Weiyu Zhou; Alison Evans Cuellar; Hong Xue
Journal:  JAMA Netw Open       Date:  2021-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.